Decheng Capital LLC Cytokinetics Inc Transaction History
Decheng Capital LLC
- $746 Billion
- Q1 2024
A detailed history of Decheng Capital LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Decheng Capital LLC holds 94,043 shares of CYTK stock, worth $5.17 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
94,043Holding current value
$5.17 Million% of portfolio
0.88%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
459Shares Held
108MCall Options Held
7.2MPut Options Held
6.2M-
Black Rock Inc. New York, NY12.4MShares$682 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$549 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$281 Million0.22% of portfolio
-
Bank Of America Corp Charlotte, NC4.78MShares$262 Million0.03% of portfolio
-
State Street Corp Boston, MA4.52MShares$248 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.17B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...